Recent WGS News
- GeneDx to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 05/22/2024 08:05:00 PM
- GeneDx Reports First Quarter 2024 Financial Results and Business Highlights • GlobeNewswire Inc. • 04/29/2024 08:05:00 PM
- GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset • GlobeNewswire Inc. • 04/23/2024 12:30:00 PM
- GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024 • GlobeNewswire Inc. • 04/04/2024 08:05:00 PM
- GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics • GlobeNewswire Inc. • 03/14/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:33:21 PM
- GeneDx to Participate in 44th Annual Cowen Health Care Conference • GlobeNewswire Inc. • 02/26/2024 09:05:02 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/23/2024 09:56:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 09:28:05 PM
- GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024 • GlobeNewswire Inc. • 02/20/2024 09:26:16 PM
- GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024 • GlobeNewswire Inc. • 02/01/2024 09:30:00 PM
- GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 01/24/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 09:10:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:58:39 PM
- GeneDx Announces Preliminary 2023 Financial Results • GlobeNewswire Inc. • 01/08/2024 01:55:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 10:03:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:25:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 02:25:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 02:24:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2023 09:05:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2023 09:04:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 09:45:08 PM
- GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with Epilepsy • GlobeNewswire Inc. • 12/01/2023 01:30:00 PM
- GeneDx to Participate in 6th Annual Evercore ISI HealthCONx Conference • GlobeNewswire Inc. • 11/28/2023 09:05:00 PM
- GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 11/20/2023 09:05:00 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM